probiotic VSL#3

DIETARY_SUPPLEMENT2 trials

Sponsors

A.O. Ospedale Papa Giovanni XXIII, Next Gen Pharma India Pvt. Ltd.

Conditions

Hepatic EncephalopathyIrritable Bowel Syndrome

Phase 3

ETOS: Minimal Hepatic Encephalopathy in Childhood and Young Adult: epidemiOlogical Study and Pilot Interventional Study

A.O. Ospedale Papa Giovanni XXIIIHepatic Encephalopathy

Start: 2013-03-31End: 2015-09-30Target: 50Updated: 2013-02-25

Study to Determine Efficacy of Probiotics in Irritable Bowel Syndrome

WithdrawnNCT02545413

Next Gen Pharma India Pvt. Ltd.Irritable Bowel Syndrome

Start: 2016-05-31End: 2017-12-31Updated: 2016-03-23